SCHEMBL5357385

SCHEMBL5357385

CCCC(CCCI)OC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.39
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
LMNA P02545 3/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
TSHR P16473 2/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CYP2C9 P11712 1/20 0.33
MAPT P10636 2/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX15 P16050 1/20 0.32
PRKCA P17252 2/20 0.32
PRKCD Q05655 2/20 0.32
AKR1A1 P14550 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10935542 0.88 CTSK (0.49) CTSKCA1CA2LMNACHRM1
SCHEMBL17805629 0.88 CTSK (0.42) CTSKCA1CA2LMNACHRM1
SCHEMBL6112007 0.86 CTSK (0.44) CTSKCA1CA2LMNAMAPT
SCHEMBL20835181 0.85 CTSK (0.42) CTSKCA2LMNAMAPTMAPK1
SCHEMBL11752280 0.85 CTSK (0.39) CTSKCA1CA2LMNACHRM1
SCHEMBL29789502 0.85 CTSK (0.42) CTSKCA2LMNAMAPTMAPK1
SCHEMBL10844707 0.82 GPR84 (0.42) CA1CA2LMNAMAPTMAPK1
SCHEMBL29102263 0.81 LMNA (0.42) CTSKCA1CA2LMNACHRM1
SCHEMBL7564855 0.81 CHRNB2 (0.41) CTSKCA1CA2LMNACHRM1
SCHEMBL5012509 0.80 GPR84 (0.45) CA2LMNAMAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4358922-A1 SOLID AND POWDERY FORMULATIONS Beiersdorf AG (DE) 2024-05-01 EP disclosed
EP-4358923-A1 SQUEEZE FOAMER AND CONCENTRATES Beiersdorf AG (DE) 2024-05-01 EP disclosed
EP-4358924-A1 COSMETIC CONCENTRATE IN THE FORM OF A FILM Beiersdorf AG (DE) 2024-05-01 EP disclosed
CN-117858620-A Antimicrobial combinations 西姆莱斯有限公司 2024-04-09 CN disclosed
EP-3922689-B1 AQUEOUS DISPERSION COATING DAW SE (DE) 2024-01-03 EP disclosed
EP-4167929-A1 METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION BASF SE (DE) 2023-04-26 EP disclosed
WO-2022268397-A1 SQUEEZE FOAMER AND CONCENTRATES BEIERSDORF AG (DE) 2022-12-29 WO disclosed
WO-2022268400-A1 COSMETIC CONCENTRATE IN THE FORM OF A FILM BEIERSDORF AG (DE) 2022-12-29 WO disclosed
WO-2022268396-A1 SOLID AND POWDERY FORMULATIONS BEIERSDORF AG (DE) 2022-12-29 WO disclosed
WO-2021255177-A1 METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION BASF SE (DE) 2021-12-23 WO disclosed
US-20040234458-A1 Self-foaming or mousse-type preparations comprising inorganic gel-forming agents, organic hydrocolloids and particulate hydrophobic and/or hydrophobed and/or oil-absorbing solid substances BEIERSDORF AG (DE) 2004-11-25 US disclosed
US-20040234559-A1 Self foaming or mousse-type preparations comprising organic hydrocolloids and particulate hydrophobic and/or hydrophobed and/or oil-absorbing solid substances BEIERSDORF AG (DE) 2004-11-25 US disclosed
US-20040202618-A1 Emulsifier mixture of fatty acid, ethylene oxide fatty acid adduct, fatty alcohol and lipid BEIERSDORF AG 2004-10-14 US disclosed
US-20040197279-A1 Self-foaming or mousse-type preparations comprising inorganic gel forming agents and organic hydrocolloids BEIERSDORF AG (DE) 2004-10-07 US disclosed
US-20040197295-A1 Foamable preparations BEIERSDORF AG 2004-10-07 US disclosed
US-20040170574-A1 Automatically foaming or foam-type preparations comprising inorganic gel formers BEIERSDORF AG (DE) 2004-09-02 US disclosed
US-20040161437-A1 Self-foaming or foam-producing preparations comprising inorganic gel-forming agents and particulate solid-state substances BEIERSDORF AG (DE) 2004-08-19 US disclosed
US-20040142006-A1 Self-foaming or foamed preparations consisting of organic hydrocolloids BEIERSDORF AG (DE) 2004-07-22 US disclosed
US-20020182234-A1 Self-foaming or foam-like preparations BEIERSDORF AKTIENGESELLSCHAFT 2002-12-05 US disclosed
JP-2000034268-A IMPROVED PRODUCTION OF CARBAMATE COMPOUND ROHM & HAAS CO 2000-02-02 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142006-A1 Self-foaming or foamed preparations consisting of organic hydrocolloids LIPA, CUTA, HAO2 CTSK 4114/4885CA1 2176/4885CA2 1214/4885
US-20020182234-A1 Self-foaming or foam-like preparations FFAR2, LIPA, FFAR1 CTSK 3851/4885CA1 1891/4885CA2 844/4885
US-20040197295-A1 Foamable preparations FASN, LIPA, FFAR1 CTSK 3750/4885CA1 3337/4885CA2 3179/4885
US-20040234559-A1 Self foaming or mousse-type preparations comprising organic hydrocolloids and particulate hydrophobic and/or hydrophobed and/or oil-absorbing solid substances HAO2, LIPA, FABP4 CTSK 4510/4885CA1 1239/4885CA2 1086/4885
US-20040234458-A1 Self-foaming or mousse-type preparations comprising inorganic gel-forming agents, organic hydrocolloids and particulate hydrophobic and/or hydrophobed and/or oil-absorbing solid substances CUTA, LIPA, CD68 CTSK 3150/4885CA1 3132/4885CA2 2415/4885
US-20040197279-A1 Self-foaming or mousse-type preparations comprising inorganic gel forming agents and organic hydrocolloids LIPA, HAO2, ELOVL3 CTSK 4452/4885CA1 2383/4885CA2 862/4885
US-20040170574-A1 Automatically foaming or foam-type preparations comprising inorganic gel formers FABP4, ELOVL3, ELOVL1 CTSK 3912/4885CA1 2001/4885CA2 783/4885
US-20040202618-A1 Emulsifier mixture of fatty acid, ethylene oxide fatty acid adduct, fatty alcohol and lipid FASN, ELOVL1, ELOVL6 CTSK 4124/4885CA1 1601/4885CA2 1116/4885
US-20040161437-A1 Self-foaming or foam-producing preparations comprising inorganic gel-forming agents and particulate solid-state substances FABP4, HBG1, HAO2 CTSK 4230/4885CA1 1544/4885CA2 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.